Invoking MCP tool get_drug_info with input {"drug_names":"PANITUMUMAB"}
MCP tool get_drug_info returned meta=None content=[TextContent(type='text', text='{
  "name": "PANITUMUMAB",
  "conceptId": "rxcui:263034",
  "approved": true,
  "immunotherapy": true,
  "antiNeoplastic": true,
  "drugAttributes": [
    {
      "name": "Year of Approval",
      "value": "2006"
    },
    {
      "name": "Drug Class",
      "value": "Therapeutic Antibodies"
    },
    {
      "name": "Drug Class",
      "value": "monoclonal antibody"
    },
    {
      "name": "Indication",
      "value": "antineoplastic agent"
    },
    {
      "name": "Drug Class",
      "value": "Pan-kinase inhibitor"
    },
    {
      "name": "Drug Class",
      "value": "MEK inhibitor"
    },
    {
      "name": "Drug Class",
      "value": "PI3K inhibitor"
    },
    {
      "name": "Drug Class",
      "value": "BRAF inhibitor"
    },
    {
      "name": "Drug Class",
      "value": "EGFR mAb inhibitor"
    },
    {
      "name": "Link to Clearity Drug Class Schematic",
      "value": "https://www.clearityfoundation.org/healthcare-pros/drugs-bio/clinicla-trial-agents/egfr-inhibitors.aspx"
    },
    {
      "name": "Drug Subclass",
      "value": "Clinical Trial Agents (Approved in other Cancers)"
    },
    {
      "name": "Drug Class",
      "value": "EGFR Inhibitors"
    },
    {
      "name": "Clinical Trial ID",
      "value": "NCT01296035"
    },
    {
      "name": "Clinical Trial ID",
      "value": "NCT00610948"
    },
    {
      "name": "Drug Class",
      "value": "Antineoplastic Agents"
    }
  ],
  "drugApprovalRatings": [
    {
      "rating": "Prescribable",
      "source": {
        "sourceDbName": "RxNorm",
        "sourceTrustLevel": {
          "level": "Expert curated"
        }
      }
    },
    {
      "rating": "Approved",
      "source": {
        "sourceDbName": "HemOnc",
        "sourceTrustLevel": {
          "level": "Expert curated"
        }
      }
    },
    {
      "rating": "Approved",
      "source": {
        "sourceDbName": "TdgClinicalTrial",
        "sourceTrustLevel": null
      }
    },
    {
      "rating": "Max Phase 4",
      "source": {
        "sourceDbName": "ChEMBL",
        "sourceTrustLevel": {
          "level": "Expert curated"
        }
      }
    }
  ]
}', annotations=None, meta=None)] structuredContent=None isError=False
### LLM OUTPUT ###
fda_approval,immunotherapy,anti_neoplastic
YES,YES,YES
